Delivery Order SPE2DB22D1202-SPE2DB25FUPT8

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,388.70 firm fixed price delivery order is for the supply of Trokendi XR 100 mg capsules. The contract has a period of performance through June 18, 2024 and was awarded on June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,969.00 fixed-price delivery order is for the supply of Trokendi XR 100 mg capsules to support federal healthcare programs. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,038.48 firm fixed-price delivery order is for the supply of Trokendi XR 200 mg capsules. The contract has an ultimate completion date of April 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is a delivery order worth $3,079.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,965.33 firm fixed price delivery order is for the medication Trokendi XR 200 mg capsules, with a performance period through December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $4,364.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 200 mg capsules and is a Firm Fixed Price Delivery Order with a completion date of March 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $7,979.87 firm fixed price delivery order is for the supply of Trokendi XR 200 mg capsules. The contract has an ultimate completion date of April 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
The federal contract award summarized is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,489.71 firm-fixed-price contract is for the supply of Trokendi XR 100 mg capsules. This order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,380.27, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division. The contract covers the delivery of Trokendi XR 200 mg capsules, a specialty pharmaceutical product, to support military healthcare programs. The award...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,053.04, is a delivery order for the supply of Trokendi XR 100 mg capsules. The contract has a period of performance through February 24, 2025 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUPT8
    Delivery Order

This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,977.92, is a delivery order for the supply of Trokendi XR 100 mg capsules. The contract has an ultimate completion date of January 16, 2025 and uses a Firm Fixed Price pricing type.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award reviewed did not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:03 AM